- MustGrow (MGRO) advances its mustard plant-based technology pipeline
- MustGrow reported successful postharvest results in both Fusarium dry rot disease control and sprout suppression
- No combination treatment products currently exist that address both disease and sprouting
- Bayer is funding and driving all laboratory, field development, regulatory work and market development
- MustGrow has designed a natural solution that uses the mustard seed’s natural defence mechanism to protect plants
- MustGrow Biologics Corp. (MGRO) is down 0.79 per cent, trading at C$3.79 at 12:24 pm EST
MustGrow Biologics Corp. (MGRO) has harnessed the mustard seed’s natural defence mechanism for the treatment of diseases, pests, and weeds.
MustGrow reported successful postharvest results in both Fusarium dry rot disease control and sprout suppression, outperforming leading synthetic chemical standards.
No combination treatment products currently exist that address both disease and sprouting.
Exclusive agreement with Bayer to evaluate MustGrow’s technologies to determine the commercial potential for preplant soil fumigation, bioherbicide applications and postharvest food preservation of potatoes including sprout inhibition.
Bayer is funding and driving all laboratory, field development, regulatory work and market development.
Successful US field trials were reported in cotton, soybeans and cucurbits, with MustGrow’s technology showing efficacy comparable to synthetic chemical standards.
Sumitomo Corporation has expanded the program development into Mexico, Peru and Chile, with a joint regulatory strategy being implemented across the Americas.
Regarding its field trials in Colombia, data confirmed reduced incidence and severity of Fusarium wilt TR4 symptoms in banana plants with no damage or phytotoxic effects on banana plants.
The Colombia banana program has transitioned, with Sumitomo Corporation now driving development and regulatory work necessary for commercialization.
Separately, MustGrow has issued 100,000 common share purchase warrants to an advisor for continued work on MustGrow’s technology in Colombia.
Each warrant shall entitle the holder to acquire one common share of the company at a price per common share to be determined according to CSE pricing policy exercisable for a period of 24 months from the date of issuance.
All warrants and underlying shares are subject to a four-month hold period from the date of issuance. The issuance of the warrants is subject to the final approval of the CSE.
MustGrow is a publicly-traded agriculture biotech company focused on providing natural science-based biological solutions for high-value crops, including fruits & vegetables and other industries.
MustGrow has designed and owns a US EPA-approved natural solution that uses the mustard seed’s natural defence mechanism to protect plants from pests and diseases.
MustGrow Biologics Corp. (MGRO) is down 0.79 per cent, trading at C$3.79 at 12:24 pm EST.
